BEAMSTART Logo

Samsung Biologics’ profit near doubles on strong orders

Korea Economic Daily LogoKorea Economic Daily1 mo ago

Samsung Biologics’ profit near doubles on strong orders - Korea Economic Daily

Quick Summary:

Samsung Biologics on Friday reported an operating profit of 983.6 billion won ($796.4 million) in 2022 on a consolidated basis, up 83% from the previous year, with sales soaring 91% to 3 trillion won.

Samsung Biologics Co., the world’s top contract drugmaker, said its profit almost doubled last year thanks to more orders as its sales surged after acquiring a nearly 50% stake in a biosimilar joint venture with Biogen Inc.

RECORD SALES ON HEALTHY ORDERSOn a separate basis, Samsung Biologics said its operating profit jumped 80% to 968.1 billion won as sales leaped 55% to a record high of 2.4 trillion won.


More Pictures

Samsung Biologics’ profit near doubles on strong orders - Korea Economic Daily (Picture 1)

or

Article Details

Category: Economy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2023-01-29 @ 11:39:28 (1 months ago)

News Timezone: GMT +8:00

News Source URL: kedglobal.com

Language: English

Article Length: 230 words

Reading Time: 2 minutes read

Sentences: 12 lines

Sentence Length: 20 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Korea Economic Daily

News ID: 4909357

View Article Analysis

About Korea Economic Daily

Korea Economic Daily Logo

Main Topics: Economy

Official Website: kedglobal.com

Update Frequency: 25 posts per day

Year Established: 1964

Headquarters: South Korea

News Last Updated: 5 hours ago

Coverage Areas: South Korea

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #91

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Samsung Biologics’ profit near doubles on strong orders" has 230 words across 12 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Which news outlet covered this story?

The story "Samsung Biologics’ profit near doubles on strong orders" was covered 1 months ago by Korea Economic Daily, a news publisher based in South Korea.

How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.

The outlet is headquartered in South Korea and publishes an average of 25 news stories per day.

It's most recent story was published 5 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #4909357
  • URL: https://beamstart.com/news/samsung-biologics-profit-near-doubles-167496073299

BEAMSTART brings you the latest news, database, and jobs from all around the world on startups, technology, and business. Stay updated with industry news, plug-in to exciting community events, and discover incredible career opportunities with the world's most innovative companies.

© Copyright 2023 BEAMSTART. All Rights Reserved.